Here, we focus on SF3B1, U2AF1, and SRSF2 splice factors as they are mutated in a subset of AML patients [16,84,85], are regulated by and interact with eIF4E [40], and play roles beyond splicing [75–77]. Here, SRSF2 is linked to acute myeloid leukemia.